Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,764 results for ""Cytochrome P-450 CYP1A2""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Xin-yi-san contains potent human CYP1A2 inhibitors and its combined use with theophylline in treatment increases adverse risks in patients.

  • Authors : Kao LT; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan

Subjects: Theophylline*/Theophylline*/Theophylline*/pharmacology ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology ; Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/metabolism

  • Source: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Jul 25; Vol. 130, pp. 155760. Date of Electronic Publication: 2024 May 18.Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exploring the relationship between caffeine metabolism-related CYP1A2 rs762551 polymorphism and team sport athlete status and training adaptations.

  • Authors : Kazan HH; Department of Medical Biology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, 06010, Türkiye.; Bulgay C

Subjects: Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/genetics ; Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/metabolism ; Athletes*

  • Source: Molecular biology reports [Mol Biol Rep] 2024 Jul 23; Vol. 51 (1), pp. 841. Date of Electronic Publication: 2024 Jul 23.Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978

Record details

Read More Add to Saved list
×
Academic Journal

Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.

  • Authors : Albitar O; School of Pharmaceutical Sciences, Universiti Sains Malaysia, USM, 11800, Gelugor, Penang, Malaysia.; Roche Pharma Research and Early Development, Basel, Switzerland.

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Clozapine*/Clozapine*/Clozapine*/analogs & derivatives ; Clozapine*/Clozapine*/Clozapine*/administration & dosage

  • Source: CNS drugs [CNS Drugs] 2024 Jul; Vol. 38 (7), pp. 571-581. Date of Electronic Publication: 2024 Jun 05.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

METTL3-induced circ_0008345 contributes to the progression of colorectal cancer via the microRNA-182-5p/CYP1A2 pathway.

  • Authors : Hou C; Department of Anorectal Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, No. 195, Tongbai North Road, Zhongyuan District, Zhengzhou, Henan, 450000, P.R. China.; Liu J

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics

  • Source: BMC cancer [BMC Cancer] 2024 Jun 14; Vol. 24 (1), pp. 728. Date of Electronic Publication: 2024 Jun 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Connect Read More Add to Saved list
×
Academic Journal

Jujuboside A Attenuates Polycystic Ovary Syndrome Based on Estrogen Metabolism Through Activating AhR-mediated CYP1A2 Expression.

  • Authors : Zhou N; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, China.; Lv W

Subjects: Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/metabolism ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/drug therapy ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/chemically induced

  • Source: Reproductive sciences (Thousand Oaks, Calif.) [Reprod Sci] 2024 Aug; Vol. 31 (8), pp. 2234-2245. Date of Electronic Publication: 2024 Mar 18.Publisher: Springer Country of Publication: United States NLM ID: 101291249 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association between CYP1A2 gene variants -163 C/A (rs762551) and -3860 G/A (rs2069514) and bladder cancer susceptibility.

  • Authors : Iqbal MS; Department of Urology, Minimally Invasive Surgery Center, Guangdong Key Laboratory of Urology, Guangzhou Urology Research Institute, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. .; Sardar N

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics ; Genetic Predisposition to Disease* ; Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/genetics

  • Source: BMC cancer [BMC Cancer] 2024 Jul 22; Vol. 24 (1), pp. 880. Date of Electronic Publication: 2024 Jul 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis.

  • Authors : Wang J; Laboratory of Exercise Biochemistry, University of Taipei, Tianmu Campus, Taipei 11153, China; Department of Emergency Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.

Subjects: Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/genetics ; Caffeine*/Caffeine*/Caffeine*/administration & dosage ; Caffeine*/Caffeine*/Caffeine*/pharmacology

  • Source: Journal of sport and health science [J Sport Health Sci] 2024 Jul; Vol. 13 (4), pp. 499-508. Date of Electronic Publication: 2023 Dec 28.Publisher: Shanghai University of Sport Country of Publication: China NLM ID: 101606001 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables.

  • Authors : Mansour K; Department of Clinical Pharmacology, Fattouma Bourguiba Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia.; Fredj NB

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Clozapine*/Clozapine*/Clozapine*/blood ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2024 Jun; Vol. 134 (6), pp. 805-817. Date of Electronic Publication: 2024 Apr 10.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

Record details

Read More Add to Saved list
×
Academic Journal

Unraveling the molecular significance of CYP1A2 (rs762551; c.-9-154 C>A) genetic variant on breast carcinoma susceptibility: Insights from case-control study and meta-analysis.

  • Authors : Alalawy AI; Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia. Electronic address: .; Sakran MI

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/Cytochrome P-450 CYP1A2*/genetics ; Genetic Predisposition to Disease*

  • Source: Pathology, research and practice [Pathol Res Pract] 2024 Sep; Vol. 261, pp. 155501. Date of Electronic Publication: 2024 Aug 05.Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

  • Authors : Huin V; University of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France; Alzheimer and Tauopathies, LabEx DISTALZ, France

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/genetics ; Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/drug therapy ; Caffeine*

  • Source: Neurobiology of disease [Neurobiol Dis] 2024 Sep; Vol. 199, pp. 106603. Date of Electronic Publication: 2024 Jul 11.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  3,764 results for ""Cytochrome P-450 CYP1A2""